Free tool
Healthcare stocks
We cover 37 companies in the Healthcare sector. The median market value in the group is $670.83M. Across the group, the median move over the past trading day is +0.15%. 36% of the 33 with a 200-day average trade above it. Price change over the past year runs from −45.9% to +17.0% across the middle 80 percent of the group, with a median of −6.4%.
Other lists in this group
Table
37 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% | Sep 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% | Aug 27, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% | Sep 23, 2026 |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% | Aug 27, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% | Sep 25, 2026 |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% | Aug 27, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% | Aug 27, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% | Aug 28, 2026 |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| ALCGM.PA | Cegedim SA | $166.24M | Small cap | −4.56% | Sep 24, 2026 |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% | Aug 27, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% | Aug 27, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | $64.69M | Micro cap | −4.19% | Aug 27, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% | Aug 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | $28.31M | Micro cap | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% | Sep 15, 2026 |
| 0VQ.DE | PureTech Health plc | — | — | +1.50% | Aug 27, 2026 |
| 6IV.DE | Inventiva S.A. | — | — | −33.03% | Sep 25, 2026 |
| ADXN.SW | Addex Therapeutics Ltd | — | — | −55.21% | Sep 14, 2026 |
| GXI.SW | Gerresheimer AG | — | — | +2.10% | Aug 27, 2026 |
| MOVE.SW | Medacta Group SA | — | — | −10.60% | Sep 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.